These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3565301)

  • 1. Altered plasma free and protein-bound sulfur amino acid levels in patients undergoing maintenance hemodialysis.
    Smolin LA; Laidlaw SA; Kopple JD
    Am J Clin Nutr; 1987 Apr; 45(4):737-43. PubMed ID: 3565301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of sulphur-containing amino acids including cysteine-homocysteine in patients on maintenance haemodialysis.
    Wilcken DE; Gupta VJ; Reddy SG
    Clin Sci (Lond); 1980 May; 58(5):427-30. PubMed ID: 7389271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulphr containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide.
    Wilcken DE; Gupta VJ
    Eur J Clin Invest; 1979 Aug; 9(4):301-7. PubMed ID: 118020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy.
    Suliman ME; Stenvinkel P; Heimbürger O; Bàràny P; Lindholm B; Bergström J
    Am J Kidney Dis; 2002 Sep; 40(3):480-8. PubMed ID: 12200798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma aminothiol oxidation in chronic hemodialysis patients.
    Himmelfarb J; McMenamin E; McMonagle E
    Kidney Int; 2002 Feb; 61(2):705-16. PubMed ID: 11849414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taurine levels in plasma and blood cells in patients undergoing routine maintenance hemodialysis.
    Jung BC; Laidlaw SA; Kopple JD
    Am J Kidney Dis; 1991 Jul; 18(1):74-9. PubMed ID: 2063858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Various forms of plasma cysteine and its metabolites in patients undergoing hemodialysis.
    Wlodek PJ; Iciek MB; Milkowski A; Smolenski OB
    Clin Chim Acta; 2001 Feb; 304(1-2):9-18. PubMed ID: 11165194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulphur amino acids in plasma and muscle in patients with chronic renal failure: evidence for taurine depletion.
    Bergström J; Alvestrand A; Fürst P; Lindholm B
    J Intern Med; 1989 Sep; 226(3):189-94. PubMed ID: 2794849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red cell and plasma amino acid concentrations in renal failure.
    Flügel-Link RM; Jones MR; Kopple JD
    JPEN J Parenter Enteral Nutr; 1983; 7(5):450-6. PubMed ID: 6685782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of fasting on leukocyte and plasma glutathione and sulfur amino acid concentrations.
    Mårtensson J
    Metabolism; 1986 Feb; 35(2):118-21. PubMed ID: 3945186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma cyst(e)ine in homocyst(e)inemia.
    Malloy MH; Rassin DK; Gaull GE
    Am J Clin Nutr; 1981 Dec; 34(12):2619-21. PubMed ID: 7315764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Some aspects of homocysteine metabolism in hemodialysis patients].
    Bednarek-Skublewska A; Buraczyńska M; Wawrzycki S; Baranowicz-Gaszczyk I; Ksiazek A
    Pol Arch Med Wewn; 2002 Nov; 108(5):1041-7. PubMed ID: 12685244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma sulfate concentration and hyperhomocysteinemia in hemodialysis patients.
    Brunetti M; Terracina L; Timio M; Saronio P; Capodicasa E
    J Nephrol; 2001; 14(1):27-31. PubMed ID: 11281340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced, free and total fractions of homocysteine and other thiol compounds in plasma from patients with renal failure.
    Hultberg B; Andersson A; Arnadottir M
    Nephron; 1995; 70(1):62-7. PubMed ID: 7617118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of mesna on plasma total homocysteine concentration in hemodialysis patients.
    Urquhart BL; Freeman DJ; Spence JD; House AA
    Am J Kidney Dis; 2007 Jan; 49(1):109-17. PubMed ID: 17185151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfur amino acids in maintenance hemodialysis patients.
    Laidlaw SA; Smolin LA; Davidson WD; Kopple JD
    Kidney Int Suppl; 1987 Oct; 22():S191-6. PubMed ID: 3480985
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical evaluation of serum albumin reductivity in patients with renal dysfunction: a comparison between conservative renal failure patients and hemodialysis patients].
    Suzuki Y; Aoki Y; Matsuyama Y; Hasegawa H; Shinohara Y; Hashimoto T; Era S; Soejima A
    Nihon Jinzo Gakkai Shi; 2008; 50(4):513-20. PubMed ID: 18546883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of N-monoacetylcystine in uraemic plasma.
    Gejyo F; Ito G; Kinoshita Y
    Clin Sci (Lond); 1981 Mar; 60(3):331-4. PubMed ID: 7237945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloramphenicol hemodialysis clearance.
    Blouin RA; Erwin WG; Dutro MP; Bustrack JA; Rowse KL
    Ther Drug Monit; 1980; 2(4):351-4. PubMed ID: 7222188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease of plasma sulfur amino acids in essential hypertension.
    Ogawa M; Takahara A; Ishijima M; Tazaki S
    Jpn Circ J; 1985 Dec; 49(12):1217-24. PubMed ID: 3938488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.